Announcements Trials
Browse Landscape

Phase

Phase 1 6Phase 2 5Phase NA 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1CNS 1

Conditions

Neuroectodermal Tumors, Primitive, Peripheral 2Neuroblastoma 2Retinoblastoma 1Ovarian Neoplasms 1Lymphoma 1Central Nervous System Neoplasms 1

Interventions

Cyclophosphamide 25Rituximab 18fludarabine phosphate 15Radiotherapy 13Methotrexate 13Peripheral Blood Stem Cell Transplantation 12Filgrastim 12Cytarabine 12Vincristine 11Melphalan 10Cyclosporine 10Busulfan 10Antilymphocyte Serum 10Exercise 9Doxorubicin 9Prednisone 7Mycophenolic Acid 7Magnetic Resonance Spectroscopy 7Etoposide 7Early Intervention, Educational 7Whole-Body Irradiation 6Surveys and Questionnaires 6Prednisolone 6Palliative Care 6Methods 6Leucovorin 6Educational Status 6Blood Specimen Collection 6Dexamethasone 5pegylated granulocyte colony-stimulating factor 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Lymphoma × Topotecan × Clear all
NCT00109798 2017-09-19

Temozolomide and Topotecan in Treating Patients With Primary CNS Lymphoma

The Methodist Hospital Research Institute

Phase NA Withdrawn
CNSLymphoid

Lymphoma, Central Nervous System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡